An additional treatment option for some allergy sufferers will soon be made available by your allergist.The FDA has approved two sublingual allergy immunotherapy tablets: grass allergy tablet, GRASTEK, was approved in early part of this month, and RAGWITEK, a sublingual allergy tablet for ragweed pollen, was approved on April 17. House dust mite allergy tablets are expected to be approved by the FDA sometime next year. Although most patients seen in an allergist's office (and by primary care physicians) have numerous environmental allergens triggering allergy symptoms, this alternative therapy will be an option for those with single allergens (grass, ragweed, or house dust mites). Further information will be available during your office consultation.
Dr. Elvin Mendez
Dr. Elvin M. Mendez is a Board-Certified Allergist & Immunologist in private practice in Port Charlotte, Florida.